Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "Bridge"

256 News Found

Maarga Mind Care launches integrative day care program to bridge mental health recovery gap
Healthcare | April 27, 2026

Maarga Mind Care launches integrative day care program to bridge mental health recovery gap

New model focuses on continuity of care, combining therapy, routine and social engagement to support long-term recovery


IKS Health to acquire TruBridge in $26.25-a-share deal to expand rural healthcare reach
Healthcare | April 27, 2026

IKS Health to acquire TruBridge in $26.25-a-share deal to expand rural healthcare reach

The deal signals a clear push to expand access to care in underserved regions


Centre of Excellence by Terumo India, AIG Hospitals to bridge IR skill gaps and reduce procedural risks
Hospitals | April 22, 2026

Centre of Excellence by Terumo India, AIG Hospitals to bridge IR skill gaps and reduce procedural risks

The programme integrates simulation-based training, expert-led sessions, and case-based discussions


K J Somaiya Hospital develops 10-minute tests to bridge India’s haemophilia diagnosis gap
Healthcare | April 21, 2026

K J Somaiya Hospital develops 10-minute tests to bridge India’s haemophilia diagnosis gap

These tests deliver results in 10–15 minutes at a cost of Rs 100–Rs 150, compared to conventional diagnostics which cost up to Rs 15,000


Red Nucleus acquires Bridge Medical Consulting with advisory support from VERTICES PARTNERS
News | April 06, 2026

Red Nucleus acquires Bridge Medical Consulting with advisory support from VERTICES PARTNERS

As part of the deal, Red Nucleus also gains indirect ownership of the company’s Indian arm


Zealand Pharma launches major US research hub in Cambridge, Massachusetts
R&D | March 26, 2026

Zealand Pharma launches major US research hub in Cambridge, Massachusetts

The Cambridge hub is designed to expand Zealand Pharma’s global research capabilities


BridgeBio reports breakthrough results in Phase 3 achondroplasia trial
Biopharma | February 16, 2026

BridgeBio reports breakthrough results in Phase 3 achondroplasia trial

Achondroplasia is a genetic condition driven by FGFR3 that affects more than stature alone


Akums and Sharda University ink MoU to bridge industry–academia gap
R&D | December 29, 2025

Akums and Sharda University ink MoU to bridge industry–academia gap

The primary goal of the collaboration is joint research into trending and next-generation molecules


FDA approves BridgeBio’s Attruby for ATTR-CM treatment
Biotech | November 26, 2024

FDA approves BridgeBio’s Attruby for ATTR-CM treatment

Attruby is the first and only approved product with a label specifying near-complete stabilization of TTR